Jigar Raythatha

2018

In 2018, Jigar Raythatha earned a total compensation of $4.7M as President and Chief Executive Officer at CONSTELLATION PHARMACEUTICALS, a 56% increase compared to previous year.

Compensation breakdown

Bonus$203,000
Option Awards$4,066,122
Salary$427,551
Other$6,581
Total$4,703,254

Raythatha received $4.1M in option awards, accounting for 86% of the total pay in 2018.

Raythatha also received $203K in bonus, $427.6K in salary and $6.6K in other compensation.

Rankings

In 2018, Jigar Raythatha's compensation ranked 2,191st out of 14,244 executives tracked by ExecPay. In other words, Raythatha earned more than 84.6% of executives.

ClassificationRankingPercentile
All
2,191
out of 14,244
85th
Division
Manufacturing
800
out of 5,765
86th
Major group
Chemicals And Allied Products
268
out of 2,128
87th
Industry group
Drugs
216
out of 1,817
88th
Industry
Pharmaceutical Preparations
167
out of 1,391
88th
Source: SEC filing on April 26, 2019.

Raythatha's colleagues

We found two more compensation records of executives who worked with Jigar Raythatha at CONSTELLATION PHARMACEUTICALS in 2018.

2018

Emma Reeve

CONSTELLATION PHARMACEUTICALS

Chief Financial Officer

2018

Adrian Senderowicz

CONSTELLATION PHARMACEUTICALS

Chief Medical Officer

News

In-depth

You may also like